Academic literature on the topic 'Syndrome coronarien aigu – Facteurs de risque'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Syndrome coronarien aigu – Facteurs de risque.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Syndrome coronarien aigu – Facteurs de risque":
Zouzou, Hanane. "Atrial fibrillation during acute coronary syndrome with ST elevation." Batna Journal of Medical Sciences (BJMS) 7, no. 2 (November 9, 2020): 79–83. http://dx.doi.org/10.48087/bjmsoa.2020.7203.
ZOUZOU, Hanane. "Complete Atrio Ventricular block during Acute Coronary Syndrome with elevated ST segment: frequency and predictive factors." Batna Journal of Medical Sciences (BJMS) 9, no. 1 (April 5, 2022): 5–9. http://dx.doi.org/10.48087/bjmsoa.2022.9102.
Hicheri, Y., D. Loghmari, R. Mabarek, S. Laajimi, Y. Hasni, A. Bouhoula, S. Sassi, and N. Chebil. "Facteurs de risque du syndrome coronarien aigu chez le sujet jeune diabétique." Annales d'Endocrinologie 81, no. 4 (September 2020): 451. http://dx.doi.org/10.1016/j.ando.2020.07.885.
Benghezel, Hichem, Asma Cheribet, Hadjer Bezzouza, Imene Khelifi, Nedjoua Alloui, Rafik Bencherif, and Hanane Boukrous. "Hyperuricemia and cardiovascular risk: study in a population admitted to the cardiology department of the University Hospital of Batna." Batna Journal of Medical Sciences (BJMS) 6, no. 2 (December 30, 2019): 109–15. http://dx.doi.org/10.48087/bjmsoa.2019.6206.
Ben Halima, G., W. Cherif, M. Ben Aoun, F. Cherif, F. Gueddiche, H. Ben Slima, M. S. Mourali, et al. "Incidence et facteurs de risque de la dépression post syndrome coronarien aigu : étude prospective auprès de 110 patients." Annales de Cardiologie et d'Angéiologie 69, no. 3 (May 2020): 125–32. http://dx.doi.org/10.1016/j.ancard.2020.03.014.
Laurent, Florian, Nicolas Segal, and Pascal Augustin. "Syndrome coronarien aigu : risque d’erreur diagnostique. A propos d’un cas." Médecine Buccale Chirurgie Buccale 16, no. 3 (July 2010): 189–90. http://dx.doi.org/10.1051/mbcb/2010022.
Roki Chaoui, I., N. Akasbi, S. Benmaamar, I. El Mezouar, and T. Harzy. "L’incidence du syndrome coronarien aigu dans la goutte et les facteurs associés." Revue du Rhumatisme 89 (December 2022): A228. http://dx.doi.org/10.1016/j.rhum.2022.10.354.
Lhermusier, T. "Quelle réponse au risque résiduel chez le patient post-syndrome coronarien aigu ? Comprendre ses fondements." Archives des Maladies du Coeur et des Vaisseaux - Pratique 2016, no. 250 (September 2016): 2–4. http://dx.doi.org/10.1016/j.amcp.2016.06.002.
Santin, A., A. N’Gako, J. Hervé, M. Salloum, M. J. Calmettes, and B. Renaud. "Stratification précoce du risque de syndrome coronarien aigu chez les patients de plus de 65 ans." Journal Européen des Urgences 21 (March 2008): A139—A140. http://dx.doi.org/10.1016/j.jeur.2008.03.180.
Guedeney, P., and J. Silvain. "Risque résiduel chez le patient après un syndrome coronarien aigu : doit-il orienter la décision thérapeutique ?" Archives des Maladies du Coeur et des Vaisseaux - Pratique 2016, no. 250 (September 2016): 9–13. http://dx.doi.org/10.1016/j.amcp.2016.07.002.
Dissertations / Theses on the topic "Syndrome coronarien aigu – Facteurs de risque":
Roth, Gwenaël. "Syndromes coronariens aigus en Guadeloupe : caractéristiques et prise en charge hospitalière de 91 cas consécutifs." Antilles-Guyane, 2007. http://www.theses.fr/2007AGUY0177.
Guadeloupe is a Frençh island located in the west Indies where, accordlng to different studies, 23 to 32 % of the population suffers from hypertenslon, 6. 6 % from diabetes and 16 to 27% from obesity. However. Epidermiology of acute coronary syndromes and care of patient in Guadeloupe have not been described specifically yet. This retrospective study was carried out on cohort of 91 patients born ln the Caribbean and living in the Guadeloupe archipelago, hospitalized at the University Hospital of Pointe-à-Pitre for acute coronary syndrome (ACS) between october 2004 and october 2005. Risk factors (RF) are over-represented with overweight affecting 65%, high blood presure 63% dyslipidemia 50% and diabetes 33% of the poputation, respectively. On the other hand smoking rate is Iow, at 20% of the population. Lack of information among this population results in late initial care. Nevertheless, compIication and death rates remain within published standards. This study couId not be as complete as expected owing to its retrospective character and to the lack of uniform information available in the medical files. However, we have been able to demonstrate the prevalance or RF in patients suffering from ACS showing the importance of improving prevention it this high risk population
Lattuca, Benoit. "Facteurs biologiques et morphologiques prédictifs de récurrences ischémiques et hémorragiques dans l’athéro-thrombose." Thesis, Sorbonne université, 2019. http://www.theses.fr/2019SORUS621.
Despite optimal medical treatment, ischemic and bleeding recurrences remain frequent after an atherothrombotic event and are associated with poor prognosis.Based on several studies including patients with different risk profiles, in stable and unstable coronary artery disease setting, the main objective of this work was to identify biological and morphological predictive factors associated with these recurrences. In addition to LDL-cholesterol and systemic inflammation level measured by CRP, copeptine appears as a biomarker that can be used in clinical practice to identify the patients with the highest risk of mortality following an acute coronary syndrome. Moreover, the biological effect to antithrombotic therapy assessed by platelet reactivity monitoring is a marker of both ischemic and bleeding risk, although a strategy of treatment adjustment targeting an optimal platelet reactivity is not associated with a significant reduction of clinical outcomes.In parallel, intracoronary imaging allows the characterization of atheroma plaques to define criteria for plaque vulnerability and risk of plaque progression. Thus, combining these morphological criteria with biological markers would be useful to identify the patients with the higher risk of recurrences.The residual risk after an atherothrombotic event must be continuously evaluated to improve therapeutic management and identify complications such as a left ventricular thrombus which is associated with a major rate of recurrences due to frequent suboptimal anticoagulant treatment.In conclusion, it appears necessary to identify the predominant risk of each patient: inflammatory, thrombotic, related to cholesterol metabolism or bleeding risk with the support of an individualized and multimodal evaluation
Gauthier, Victoria. "Étude du pronostic des accidents vasculaires cérébraux et des syndromes coronaires aigus en population : étude réalisée à partir du registre des AVC de Lille et des trois registres français des syndromes coronaires aigus." Electronic Thesis or Diss., Université de Lille (2022-....), 2023. http://www.theses.fr/2023ULILS004.
Cardiovascular diseases are an important cause of morbidity and mortality. The monitoring of epidemiological indicators of stroke and Acute Coronary Syndromes (ACS) through population registers plays an important role in the evaluation of public policies. In addition, as acute-phase care progresses rapidly over time, it is essential to be able to monitor its evolution, to estimate the potential impact of new treatments in real life. Our objective was to characterize the prognosis of strokes and ACS in the population and it was organized according to 3 axes.In a first study, we studied lethality after stroke in the Lille stroke registry. Lethality at 28 days, in subjects aged >=35 years, was 48% after hemorrhagic stroke, 3% after large artery atherosclerosis or lacunar stroke and varied from 15 to 20% for the other subtypes of ischemic strokes. In the acute phase, the time between the onset of symptoms and first contact with the care services was exceeded in 40% of patients, not allowing revascularization. Age, severity and stroke etiology were the main predictors of 28-day case fatality. The higher lethality observed in women compared to men was mainly explained by their advanced age. AF, an underdiagnosed and undertreated comorbidity found in 57% of cardioembolic strokes, was also a risk factor associated with lethality.In a second work we studied the evolution of the management and the lethality of ACS in the French registers of ACS between 2006 and 2016. In patients aged 35-74, residing in one of the 3 geographical areas monitored by MONICA registries and hospitalized for an ACS, the lethality was 8% at 28 days. These rates varied by type of ACS (9% after STEMI, 6% after NSTEMI at 1 year), but did not differ between men and women. On the therapeutic level, our results showed a more qualitative than quantitative evolution with an improvement in the effectiveness of management in the acute phase and prescriptions related to new generation therapies. However, while the characteristics of the events tend to converge between men and women, a slight deficit in management was still observed in women compared to men.In a third part, we focused on patients who had survived their incident event to study the risk of recurrence after an ACS in the French ACS registers. The recurrence rate after an incident ACS remained high (~20% over 9 years), mainly the year following the incident event (6.7%) and did not depend on the type of the first event (STEMI/NSTEMI/UA), or sex. Impaired LVEF and complications from the incident event were major risk factors for recurrence. Recurrence rates decreased between 2009 and 2017.In conclusion, acute vascular events remain diseases with a serious prognosis whose etiology and physiopathological mechanism are an important and independent source of prognostic variability. It is important to continue improving the management of women for whom the progression is not as optimal as for men and to pay particular attention to the severity factors of stroke and ACS. Thus, by providing precise epidemiological indicators, the continuous recording of acute vascular events in a geographically defined territory, has enabled the monitoring of the state of vascular health in the population and has enabled us to study the prognosis of strokes and ACS according to the precise characteristics of the event
Grosdidier, Charlotte. "Anti-plaquettaires et risque hémorragique : rôle du CD40L." Thesis, Aix-Marseille, 2014. http://www.theses.fr/2014AIXM5063/document.
Aspirin and thienopyridine are the therapy for patients with percutaneous coronary intervention after ACS. The level of platelet inhibition by thienopyridine varies between patients, this variability, multifactorial, is associated with adverse clinical outcomes. Treatment efficacy was evaluated mainly on the association between poor thienopyridine response and thrombotic events but less on the principal side effect: bleeding complications. Platelet play a key role in atherosclerosis and thrombosis, notably via CD40L.I studied platelet factors that influence the bleeding risk in these patients and brought a new highlight on platelet function less known such as inflammation.P450 cytochrome genetic variants (2C19*2 and 2C19*17) influence platelet response to thienopyridines. There is a relation between platelet reactivity and bleeding events. A very low on-treatment platelet reactivity (VASP<10 %) is a predictor of bleeding and is mainly observed with prasugrel treatment. We then focussed on a marker of platelet inflammatory status, CD40L. Its release by platelets depends on P2Y12 signalling, whereas its surface expression is less dependent on this signalling pathway. A low platelet-CD40L surface expression is associated with bleeding events in these patients We show that genetic background on thienopyridine treatment efficacy is related to bleeding risk and that other platelet parameters influence the bleeding risk independently of platelet aggregation inhibition. Thus, a molecule of inflammation, CD40L, would be a link between inflammation and bleeding/thrombosis equilibrium
Labriolle, Axel de. "Caractérisation échographique de la pathologie carotidienne athéromateuse : étude des corrélations entre la pathologie athéromateuse carotidienne et coronaire." Thesis, Tours, 2009. http://www.theses.fr/2009TOUR3118/document.
Background: Carotid echo Doppler (EDC) is an interesting tool to define the cardio vascular risk (RCV) of patients. However its performances could be increased with creation of new parameters The studies n°1, 2 and 3 studied the correlations between the plaque volume index (IVP) and the currently used echographic parameters. Studies n° 4 and 5 studied the contribution of EDC for evaluating the RCV in patients with an acute coronary syndrome (ACS). Materials: Studies n°1,2 and 3 were performed on 93 patients with EDC. Studies n° 4 and 5 were performed on 152 patients with an SCA and EDC systematically achieved. Results: IVP was not correlated with the parameters currently used to quantify carotid atheroma. IVP was more sensible than the stenosis degree to detect the changes in carotid atheroma. EDC performed in all patients with an SCA could not be justified. Performed in elderly and diabetic patients, this tool was very useful to detect severe stenosis with an impact on patients’s management. Asymptomatic Carotid narrowing between was found to have a prognostic value. Conclusion: EDC is an interesting tool to understand the RCV. Its better use (quantitative and qualitative) should allow to reduce the CV morbid mortality
Rochemont, Rita Devi Surya. "Insuffisance rénale terminale et maladies cardiovasculaires : le poids des maladies chroniques en Guyane The epidemiology of acute coronary syndromes in French Guiana The epidemiology and emergency care of stroke in French Guiana : a multicenter cohort study A prospective study of Health inequalities and the epidemiology of stroke in French Guiana End stage renal disease in French Guiana (data from R.E.I.N registry) : South American or French ? End stage renal disease as a symptom of health inequalities in French Guiana." Thesis, Guyane, 2019. http://www.theses.fr/2019YANE0012.
Non communicable chronic diseases, notably cardiovascular diseases are one of the main causes of death. Numerous studies have studied risk factors throughout the world. In French Guiana, most research themes focus on tropical infectious diseases. However, the epidemiologic transition is well underway, and cardiovascular diseases represent a major public health problem. Hence strokes and coronary syndrome are the main cause of premature death after accidents. As elsewhere, chronic renal failure also represents a rising problem in French Guiana. French Guiana is an overseas French Territory with a large Afro-caribbean population profile in terms of cultural and socioeconomic aspects with a French health system. Despite the universal healthcare system, there are frequent health inequalities. Diabetes and high blood pressure are 2 major risk factors for cardiovascular diseases and for end stage renal failure. In order to alleviate the lack of epidemiologic data, the present work aims to describe the epidemiology of these diseases in French Guiana using different data sources: the hospital’s « programme médicalisé des systems d’information (PMSI) », the data from the INDIA prospective cohort a collaboration between the clinical investigation center in Cayenne and Dijon hospital, and data from the end stage renal disease registry. These results will hopefully help improve access to care, and reduce mortality.The present thesis thus shows the particularities of the epidemiology of these highly incident and fatal diseases. It also shows the importance of health inequalities in French Guiana, as for other diseases, the more vulnerable populations become sick younger, with more severe diseases, and more deaths. Hypertension and diabetes are prime targets for preventive interventions, with special efforts to reach the most vulnerable social groups
Garcia, Garrido M. Lluïsa. "Besoins d'apprentissage et sentiment d'auto-efficacité chez des patients atteints d'un syndrome coronarien aigu, à Girona, Espagne." Thesis, 2006. http://hdl.handle.net/1866/17135.
Huynh, Thi Thanh Thao. "Bridging Knowledge Gaps in the Management of Acute Coronary Syndromes." Thèse, 2013. http://hdl.handle.net/1866/10122.
Background Acute occlusion of an artery of the heart results in acute coronary syndromes (ACS), either with ST-segment elevation (STEMI) or without ST-segment elevation (1). STEMI requires urgent treatment to restore coronary artery flow either by primary percutaneous coronary intervention (PCI) or fibrinolytic therapy (FL) (2). Although several randomized controlled trials (RCTs) demonstrate the superiority of primary PCI in reducing mortality compared to FL (2), the benefit of primary PCI over FL remains uncertain in unselected “real-life” patients (3,4). FL can be administered either in the pre-hospital setting (i.e., pre-hospital FL (PHL)) or at the hospital. PHL is rarely available outside Europe (5,6). Insights into the organization of PHL systems of care may promote more widespread use of PHL. Risk stratification of ACS patients should be prompt to ensure timely PCI for high-risk patients and to avoid unnecessary intervention in low-risk patients (7). Despite the availability of numerous ACS risk scores, there is still no simple risk score that can be easily applied in the initial management of ACS patients (8). Objectives The objectives of this doctoral dissertation were to address these current knowledge gaps in the optimal management of ACS. The objectives were to: 1) evaluate the efficacy, effectiveness, and safety of primary PCI and FL, (2) describe the infrastructure, processes and outcomes of several international PHL systems; and (3) develop and validate a novel clinical risk score for early risk stratification of ACS patients. Methods To address these objectives, I completed Bayesian hierarchical random-effects meta-analyses of published RCTs and observational studies which compare primary PCI and FL in patients with STEMI. I undertook a survey of the infrastructure, processes and outcomes of PHL in several European and North American pre-hospital emergency systems. Finally, I developed and validated an ACS risk score called the Canadian ACS (C-ACS). Results Primary PCI was superior to FL in reducing short-term mortality in RCTs and observational studies. However, the long-term survival benefit of primary PCI was noted only in RCTs, and not in the observational studies. PHL can be effectively delivered by health care professionals with variable levels of expertise. The new risk score, C-ACS, has good discriminant properties for short- and long-term mortality in patients with ACS. Conclusions The first manuscript of this dissertation has been recognized as one of the most valuable recent publications in STEMI management and has contributed to reorganization of STEMI care in Ontario. The other two manuscripts in this dissertation provide practical information and tools for health professionals caring for patients with ACS. In summary, this doctoral dissertation has and will continue to contribute to improve access to high quality care for patients with ACS.
Books on the topic "Syndrome coronarien aigu – Facteurs de risque":
Sars Unmasked Risk Communication Of Pandemics And Influenza In Canada. McGill-Queen's University Press, 2010.